(Q35580481)

9 August 2017

1 reference

title

Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation (English)

1 reference

9 August 2017

1 reference

2

Lesley J Scott

1 reference

9 August 2017

3

Monique P Curran

1 reference

9 August 2017

Susan J Keam

1

1 reference

9 August 2017

language of work or name

1 reference

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

63

1 reference

9 August 2017

issue

22

1 reference

9 August 2017

page(s)

2521-2554

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363220-00016

9 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363220-00016

Natural History of Choroidal Neovascularization in Degenerative Myopia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200363220-00016

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Vascular targeting in photodynamic occlusion of subretinal vessels

1 reference

12 December 2020

Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis

1 reference

12 December 2020

Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series

1 reference

12 December 2020

Adverse reaction characterized by chest pain, shortness of breath, and syncope associated with verteporfin (visudyne).

1 reference

12 December 2020

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation

1 reference

12 December 2020

Photodynamic effects on choroidal neovascularization and physiological choroid

1 reference

12 December 2020

Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples

1 reference

12 December 2020

Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group

1 reference

12 December 2020

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

1 reference

12 December 2020

Cellular distribution and phototoxicity of benzoporphyrin derivative and Photofrin

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

1 reference

12 December 2020

Natural history of choroidal neovascularization in high myopia

1 reference

12 December 2020

Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies

1 reference

12 December 2020

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

12 December 2020

Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents

1 reference

12 December 2020

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

1 reference

12 December 2020

Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group

1 reference

12 December 2020

Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model

1 reference

12 December 2020

Relation between macular morphology and visual function in patients with choroidal neovascularisation of age related macular degeneration

1 reference

12 December 2020

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes

1 reference

12 December 2020

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study

1 reference

12 December 2020

Recent advances in the management of age-related macular degeneration

1 reference

12 December 2020

Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization

1 reference

12 December 2020

Visual Prognosis of Disciform Degeneration in Myopia

1 reference

12 December 2020

Macular Lesions in Blacks with the Presumed Ocular Histoplasmosis Syndrome

1 reference

12 December 2020

Sequence of Early Vascular Events after Photodynamic Therapy

1 reference

12 December 2020

Histopathological changes following photodynamic therapy in human eyes.

1 reference

12 December 2020

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative

1 reference

12 December 2020

Photodynamic therapy: Recommendations for indication and treatment

1 reference

12 December 2020

Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin

1 reference

12 December 2020

Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy

1 reference

12 December 2020

The quality of life in patients with pathologic myopia.

1 reference

12 December 2020

Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment

1 reference

12 December 2020

Treatment of age-related macular degeneration

1 reference

12 December 2020

Photodynamic therapy in immune (non-oncological) disorders: focus on benzoporphyrin derivatives

1 reference

12 December 2020

Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia

1 reference

12 December 2020

A potentially life-threatening adverse reaction to verteporfin

1 reference

12 December 2020

Ocular histoplasmosis.

1 reference

12 December 2020

Age-related macular degeneration

1 reference

12 December 2020

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

1 reference

12 December 2020

Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model

1 reference

12 December 2020

Age-related macular degeneration

1 reference

12 December 2020

1 reference

12 December 2020

Dye-sensitized photodynamic inactivation of cells

1 reference

12 December 2020

Pathologic myopia: where are we now?.

1 reference

12 December 2020

Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome

1 reference

12 December 2020

Preliminary studies on a more effective phototoxic agent than hematoporphyrin

1 reference

12 December 2020

Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy

1 reference

12 December 2020

In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization

1 reference

12 December 2020

Clinicopathologic correlation of surgically removed submacular tissue.

1 reference

12 December 2020

Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA)

1 reference

12 December 2020

Neutrophil margination as a possible mechanism for verteporfin infusion-associated pain

1 reference

12 December 2020

Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group

1 reference

12 December 2020

Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin

1 reference

12 December 2020

In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives

1 reference

12 December 2020

Clinical pharmacokinetics of verteporfin

1 reference

12 December 2020

Global data on blindness

1 reference

12 December 2020

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

1 reference

12 December 2020

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

12 December 2020

Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome

1 reference

12 December 2020

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

12 December 2020

1 reference

12 December 2020

Improvement in quality of life from photodynamic therapy: a Canadian perspective

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

12 December 2020

Epidemiology of age-related maculopathy.

1 reference

12 December 2020

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

12 December 2020

Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

1 reference

12 December 2020

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

1 reference

12 December 2020

Economic evaluation of photodynamic therapy with verteporfin

1 reference

12 December 2020

Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation

1 reference

12 December 2020

Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin

1 reference

12 December 2020

Follow-up Study of Presumed Ocular Histoplasmosis Syndrome

1 reference

12 December 2020

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

1 reference

12 December 2020

The etiology of the presumed ocular histoplasmosis syndrome

1 reference

12 December 2020

How does photodynamic therapy work?

1 reference

12 December 2020

The second eye of patients with senile macular degeneration

1 reference

12 December 2020

Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.

1 reference

12 December 2020

The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

12 December 2020

Long-term results of laser treatment in the ocular histoplasmosis syndrome

1 reference

12 December 2020

Verteporfin infusion-associated pain

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

12 December 2020

Update in retina: photodynamic therapy for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

1 reference

12 December 2020

10.2165/00003495-200363220-00016

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1021289809

0 references

1 reference